| 1 |
Time-consuming and expensive data quality monitoring procedures persist in clinical trials: A national survey |
|
|
| Lauren Houston,Allison Martin,Ping Yu,Yasmine Probst |
|
| Contemporary Clinical Trials. 2021; 103: 106290 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verification |
|
|
| Osamu Yamada,Shih-Wei Chiu,Munenori Takata,Michiaki Abe,Mutsumi Shoji,Eri Kyotani,Chiyo Endo,Minami Shimada,Yuko Tamura,Takuhiro Yamaguchi |
|
| Clinical Trials. 2021; 18(2): 158 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Implementing an automated monitoring process in a digital, longitudinal observational cohort study |
|
|
| Lisa Lindner,Anja Weiß,Andreas Reich,Siegfried Kindler,Frank Behrens,Jürgen Braun,Joachim Listing,Georg Schett,Joachim Sieper,Anja Strangfeld,Anne C. Regierer |
|
| Arthritis Research & Therapy. 2021; 23(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Heterogeneity in clinical research data quality monitoring: a national survey |
|
|
| Lauren Houston,Ping Yu,Allison Martin,Yasmine Probst |
|
| Journal of Biomedical Informatics. 2020; : 103491 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology |
|
|
| Sarah C. Lotspeich,Mark J. Giganti,Marcelle Maia,Renalice Vieira,Daisy Maria Machado,Regina Célia Succi,Sayonara Ribeiro,Mario Sergio Pereira,Maria Fernanda Rodriguez,Gaetane Julmiste,Marco Tulio Luque,Yanink Caro-Vega,Fernando Mejia,Bryan E. Shepherd,Catherine C. McGowan,Stephany N. Duda |
|
| Journal of Clinical and Translational Science. 2020; 4(2): 125 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan |
|
|
| Tomohisa Sudo,Akihiro Sato |
|
| Therapeutic Innovation & Regulatory Science. 2017; 51(5): 589 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Efficient Source Data Verification Using Statistical Acceptance Sampling |
|
|
| Rutger M. van den Bor,Bas J. Oosterman,Martinus B. Oostendorp,Diederick E. Grobbee,Kit C. B. Roes |
|
| Therapeutic Innovation & Regulatory Science. 2016; 50(1): 82 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The impact of clinical trial monitoring approaches on data integrity and cost—a review of current literature |
|
|
| Rasmus Olsen,Asger Reinstrup Bihlet,Faidra Kalakou,Jeppe Ragnar Andersen |
|
| European Journal of Clinical Pharmacology. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Data-driven risk identification in phase III clinical trials using central statistical monitoring |
|
|
| Catherine Timmermans,David Venet,Tomasz Burzykowski |
|
| International Journal of Clinical Oncology. 2016; 21(1): 38 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Evolving quality standards for large-scale registries: the GARFIELD-AF experience |
|
|
| Keith A.A. Fox,Bernard J. Gersh,Sory Traore,A. John Camm,Gloria Kayani,Anders Krogh,Shweta Shweta,Ajay K. Kakkar |
|
| European Heart Journal - Quality of Care and Clinical Outcomes. 2016; : qcw058 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
A Data-Driven Approach to Risk-Based Source Data Verification |
|
|
| Elizabeth Nielsen,DeAnn Hyder,Chao Deng |
|
| Therapeutic Innovation & Regulatory Science. 2014; 48(2): 173 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Key Considerations in the Transition to Risk-Based Monitoring |
|
|
| Michael J. Rosenberg |
|
| Therapeutic Innovation & Regulatory Science. 2014; 48(4): 428 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials |
|
|
| Nicole Sheetz,Brett Wilson,Joanne Benedict,Esther Huffman,Andy Lawton,Mark Travers,Patrick Nadolny,Stephen Young,Kyle Given,Lawrence Florin |
|
| Therapeutic Innovation & Regulatory Science. 2014; 48(6): 671 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Taking the 'Risk' out of risk-based monitoring |
|
|
| Ashwaria Gupta |
|
| Perspectives in Clinical Research. 2013; 4(4): 193 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
